Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Health Discovery's Revenue for the
three
months ended in Sep. 2021 was $0.00 Mil. Health Discovery's average Accounts Receivable for the
three
months ended in Sep. 2021 was $0.00 Mil.
Health Discovery (OTCPK:HDVY) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Health Discovery Receivables Turnover Related Terms
Health Discovery Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Health Discovery's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HDVY vs SSYNF, PAXH, EWLL: Receivables Turnover Comparison
For the Health Information Services subindustry, Health Discovery's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Discovery Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Health Discovery's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Health Discovery's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Discovery (HDVY) has a Receivables Turnover of 0.00 as of Sep. 2021. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Health Discovery and its competitors.
Is Health Discovery's Receivables Turnover too high?
Health Discovery's current Receivables Turnover is 0.00.
How does Health Discovery's Receivables Turnover compare to SSYNF and PAXH?
Health Discovery's Receivables Turnover of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median Receivables Turnover is 7.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.75, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Health Discovery and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Discovery's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Discovery stock overvalued right now?
Health Discovery (HDVY) has a current Receivables Turnover of 0.00. The current Receivables Turnover is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Health Discovery (HDVY), the current Receivables Turnover is 0.00 as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Health Discovery Corp is a machine learning company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. The company operates in the field of molecular diagnostics where such tools are critical to scientific discovery. It owns a patent portfolio of machine learning technology, including certain pioneer patents on Support Vector Machine. The company recognizes revenue principally from license and royalty fees for intellectual property and from development agreements with research partners.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HDVY has been successfully added to your 
